Loading
Total declarations
Companies
▲ Purchases (41 ops.)
▼ Sales (0 ops.)
Latest filing published 20 Oct 2026 for EXAGEN INC., €93k.
Filing timeline
BuySaleJorey Chernett
Insider track record
Disclosed buys
41
Disclosed sells
0
Signal history
Closed purchases
Market purchases
41
Positive at T+90
84%
Median T+90
+42.5%
Based on 37 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +3.6%Entry US$6.40 · Close 20 Oct 2026 US$6.63
- -40.2%Entry US$3.15 · Close 16 Oct 2026 US$1.88
- +20.9%Entry US$0.05 · Close at T+30 US$0.06
- +5.9%Entry US$1.78 · Close 16 Oct 2026 US$1.88
- +10.2%Entry US$0.05 · Close at T+90 US$0.06
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jorey Chernett: trading record in brief
All 41 filings of Jorey Chernett are purchases, all published in 2026 between March 4 and October 20, and all filed as 10% Owner of four companies: Starling Oncology, Inc. (15 purchases), Airsculpt Technologies, Inc. (13), Neuronetics, Inc. (12) and Exagen Inc. (1). There is no sale, grant or option exercise.
The total reaches EUR 7,551,265, with a median of EUR 125,863. The three largest are EUR 710,595 on March 18 at Neuronetics, EUR 666,536 on March 13 at Starling Oncology and EUR 585,171 on March 27 at Neuronetics.
For the 37 purchases with a 90-day result, the stored median is 42.5%, with 84% positive (recorded past results, not a forecast). Filings are published a median of 1 day after the trade.
8, 8 and 8 trades by Chernett fall within 30 days of colleagues at Neuronetics, Inc., in that order. In the same direction: 0, 0 and 0. Colleagues in order: Keith J. Sullivan, Steven Pfanstiel and William Andrew Macan.
Companies and markets linked to Jorey Chernett
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations41 total
14,000 shares@ US$7.460.058% mcap100.0% of flowCommon StockSEC:0001193805-26-001382:0
Canonical exit: 17 Jan 2027 (T+90)
12,000 shares@ US$6.540.012% mcap100.0% of flowCommon StockSEC:0000921895-26-002203:0
Canonical exit: 12 Nov 2026 (T+90)
14,000 shares@ US$3.160.021% mcap1.3% of flowCommon StockSEC:0000921895-26-002204:0
Canonical exit: 12 Nov 2026 (T+90)
18,000 shares@ US$5.275.0% of flowCommon StockSEC:0000921895-26-001852:0
Canonical exit: 19 Oct 2026 (T+90)
35,000 shares@ US$1.780.030% mcap1.8% of flowCommon StockSEC:0000921895-26-001811:0
Canonical exit: 12 Oct 2026 (T+90)
15,000 shares@ US$5.854.6% of flowCommon StockSEC:0000921895-26-001798:0
Canonical exit: 8 Oct 2026 (T+90)
18,000 shares@ US$5.024.4% of flowCommon StockSEC:0000921895-26-001657:0
Canonical exit: 21 Sept 2026 (T+90)
12,000 shares@ US$4.752.9% of flowCommon StockSEC:0000921895-26-001564:0
Canonical exit: 2 Sept 2026 (T+90)
5,000 shares@ US$4.051.0% of flowCommon StockSEC:0000921895-26-001466:0
Canonical exit: 17 Aug 2026 (T+90)
33,500 shares@ US$4.077.0% of flowCommon StockSEC:0000921895-26-001466:1
Canonical exit: 18 Aug 2026 (T+90)
100,000 shares@ US$1.580.063% mcap4.5% of flowCommon StockSEC:0000921895-26-001056:0
Canonical exit: 19 Jul 2026 (T+90)
100,000 shares@ US$1.510.060% mcap4.3% of flowCommon StockSEC:0000921895-26-001056:1
Canonical exit: 20 Jul 2026 (T+90)
40,000 shares@ US$2.540.052% mcap5.2% of flowCommon StockSEC:0000921895-26-001030:0
Canonical exit: 16 Jul 2026 (T+90)
20,000 shares@ US$2.600.027% mcap2.6% of flowCommon StockSEC:0000921895-26-000989:0
Canonical exit: 13 Jul 2026 (T+90)
20,000 shares@ US$3.103.2% of flowCommon StockSEC:0000921895-26-000958:0
Canonical exit: 8 Jul 2026 (T+90)
60,000 shares@ US$2.939.0% of flowCommon StockSEC:0000921895-26-000944:0
Canonical exit: 6 Jul 2026 (T+90)
90,000 shares@ US$2.8213.2% of flowCommon StockSEC:0000921895-26-000915:0
Canonical exit: 2 Jul 2026 (T+90)
385,442 shares@ US$1.2514.2% of flowCommon StockSEC:0000921895-26-000835:0
Canonical exit: 28 Jun 2026 (T+90)
27,429 shares@ US$2.964.2% of flowCommon StockSEC:0000921895-26-000823:0
Canonical exit: 25 Jun 2026 (T+90)
500,000 shares@ US$1.3519.7% of flowCommon StockSEC:0000921895-26-000822:0
Canonical exit: 25 Jun 2026 (T+90)
25,000 shares@ US$1.440.9% of flowCommon StockSEC:0000921895-26-000813:1
Canonical exit: 24 Jun 2026 (T+90)
50,000 shares@ US$3.158.1% of flowCommon StockSEC:0000921895-26-000814:0
Canonical exit: 24 Jun 2026 (T+90)
125,000 shares@ US$1.405.1% of flowCommon StockSEC:0000921895-26-000813:0
Canonical exit: 23 Jun 2026 (T+90)
125,000 shares@ US$3.1120.0% of flowCommon StockSEC:0000921895-26-000796:0
Canonical exit: 22 Jun 2026 (T+90)
50,000 shares@ US$2.917.5% of flowCommon StockSEC:0000921895-26-000802:0
Canonical exit: 21 Jun 2026 (T+90)
25 of 41 declarations
